News
ICB&DD 19th Annual Symposium "Drug Discovery & AI: Advances and New Directions" (read more)
ICB&DD Welcomes Dr. Anupam Banerjee as a New Associate Member
Dr. Anupam Banerjee, Senior Postdoctoral Research Associate, Laufer Center for Physical
and Quantitative Biology (read more)
See photo galery Friday June 6
See photo galery Saturday June 7
Dr. Veronique Gouverneur Receives The Ojima Distinguished Lectureship Award in Chemistry
Dr. Veronique Gouverneur gave a lecture at The Ojima Distinguished Lectureship Award
in Chemistry on April 25 at the Wang Center, SBU.(Read more)
ICB&DD Welcomes New Members: Drs. Jeffrey Gustafson and Wenchao Qu
Dr. Jeffrey Gustafson, Professor of Department of Chemistry (read more)
Dr. Wenchao Qu, Associate Professor of Department of Psychiatry, Stony Brook Renaissance
School of Medicine (read more)
Drug to Treat Neuropathy Advances in Clinical Trials
The drug, ART26.12, is being developed by Artelo Biosciences, based in Solana Beach, CA. The compound was discovered and initially developed by Drs., Iwao Ojima and Martin Kaczocha (read more)
Message from the Director
Dr. Iwao Ojima, Distinguished Professor and Director, ICB&DD
Welcome to the Institute of Chemical Biology & Drug Discovery
The primary objective of ICB&DD is to establish a world-class “Center of Excellence” in chemical biology and drug discovery at Stony Brook. The rapid and impressive advancement of chemical biology in the last decades clearly demonstrated that solutions for vast majority of medical problems rely on the understanding of the molecular basis of diseases, therapeutic targets, drug actions, and drug resistance. ICB&DD promotes highly productive interdisciplinary and multidisciplinary research bridging the West, East and South campuses as well as Brookhaven National Laboratory to attack major and significant biomedical problems to find solutions including the discovery of novel therapeutic drugs. ICB&DD significantly contributes to the advancement of a truly comprehensive biomedical research enterprise from molecular science to clinic at Stony Brook.
